Poulton Jeffrey V.
CIK 0001782962
EVP, Chief Financial OfficerDirector
Filings
24
Latest Mar 6, 2026
Issuers covered
3
Showing
24 of 24
Page 1
Track record
123 of 123 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 123 | 65% | +1.8% | +1.1% | +13.1% | -9.6% |
| 90 days | 123 | 59% | +0.3% | +3.3% | +13.7% | -25.7% |
| 180 days | 83 | 37% | -25.2% | -0.9% | +28.2% | -84.1% |
| 365 days | 63 | 8% | -35.1% | -31.7% | +26.9% | -75.7% |
Issuers
Companies where Poulton Jeffrey V. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 19 | Mar 6, 2026 |
| CRVO | Cervomed Inc. | 3 | Jun 25, 2025 |
| FIXX | Homology Medicines, Inc. | 2 | Jun 15, 2023 |
All filings
24 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|